{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:48:02Z","timestamp":1792090082582,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10203-3","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:04:12Z","timestamp":1696849452000},"page":"2374-2383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Qian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Ungchusri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"DiSabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuong","family":"Van Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"issue":"4","key":"10203_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","volume":"28","author":"R El-Diwany","year":"2019","unstructured":"El-Diwany R, Pawlik TM, Ejaz A (2019) Intrahepatic cholangiocarcinoma. Surg Oncol Clin. 28(4):587\u2013599","journal-title":"Surg Oncol Clin."},{"issue":"7","key":"10203_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/bjs.10676","volume":"105","author":"X-F Zhang","year":"2018","unstructured":"Zhang X-F, Beal E, Bagante F et al (2018) Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. J Brit Surg. 105(7):848\u2013856","journal-title":"J Brit Surg."},{"issue":"1","key":"10203_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14737140.2022.1999809","volume":"22","author":"DB Hewitt","year":"2022","unstructured":"Hewitt DB, Brown ZJ, Pawlik TM (2022) Surgical management of intrahepatic cholangiocarcinoma. Expert Rev Anticancer Ther. 22(1):27\u201338","journal-title":"Expert Rev Anticancer Ther."},{"issue":"1","key":"10203_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","volume":"6","author":"J Edeline","year":"2020","unstructured":"Edeline J, Touchefeu Y, Guiu B et al (2020) Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 6(1):51\u201359","journal-title":"JAMA Oncol."},{"issue":"7","key":"10203_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jvir.2020.02.008","volume":"31","author":"S Buettner","year":"2020","unstructured":"Buettner S, Braat AJ, Margonis GA et al (2020) Yttrium-90 radioembolization in intrahepatic cholangiocarcinoma: a multicenter retrospective analysis. J Vasc Interv Radiol. 31(7):1035-1043. E2","journal-title":"J Vasc Interv Radiol."},{"issue":"3","key":"10203_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/hep-2017-0005","volume":"4","author":"O Akinwande","year":"2017","unstructured":"Akinwande O, Shah V, Mills A et al (2017) Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution image-based efficacy and comparative toxicity. Hepat Oncol. 4(3):75\u201381","journal-title":"Hepat Oncol."},{"issue":"3","key":"10203_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/bjc.2016.191","volume":"115","author":"C Mosconi","year":"2016","unstructured":"Mosconi C, Gramenzi A, Ascanio S et al (2016) Yttrium-90 radioembolization for unresectable\/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study. Br J Cancer. 115(3):297\u2013302","journal-title":"Br J Cancer."},{"issue":"8","key":"10203_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","volume":"24","author":"S Mouli","year":"2013","unstructured":"Mouli S, Memon K, Baker T et al (2013) Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Rad. 24(8):1227\u20131234","journal-title":"J Vasc Interv Rad."},{"issue":"5","key":"10203_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000516880","volume":"10","author":"Q Yu","year":"2021","unstructured":"Yu Q, Liu C, Pillai A, Ahmed O (2021) Twenty years of radiation therapy of unresectable intrahepatic cholangiocarinoma: internal or external? a systematic review and meta-analysis. Liver Cancer 10(5):433\u2013450. https:\/\/doi.org\/10.1159\/000516880","journal-title":"Liver Cancer"},{"issue":"5","key":"10203_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00270-016-1555-3","volume":"40","author":"O Ahmed","year":"2017","unstructured":"Ahmed O, Patel MV, Masrani A et al (2017) Assessing intra-arterial complications of planning and treatment angiograms for Y-90 radioembolization. Cardiovasc Int Radiol. 40(5):704\u2013711","journal-title":"Cardiovasc Int Radiol."},{"issue":"4","key":"10203_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000508386","volume":"7","author":"W Badar","year":"2020","unstructured":"Badar W, Van (2020) Ha T, Zangan S, et al Yttrium-90 radioembolization therapy for combined hepatocellular and cholangiocarcinoma. Gastrointest Tumors. 7(4):144\u2013150","journal-title":"Gastrointest Tumors."},{"issue":"7","key":"10203_CR12","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1007\/s00330-022-08585-x","volume":"32","author":"W L\u00fcdemann","year":"2022","unstructured":"L\u00fcdemann W, Kahn J, Pustelnik D et al (2022) Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection. Eur Radiol 32(7):4687\u20134698. https:\/\/doi.org\/10.1007\/s00330-022-08585-x","journal-title":"Eur Radiol"},{"issue":"6","key":"10203_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.surg.2019.06.005","volume":"166","author":"F Bagante","year":"2019","unstructured":"Bagante F, Spolverato G, Merath K et al Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Endo I, Pawlik TM (2019) Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection. Surgery 166(6):983\u2013990. https:\/\/doi.org\/10.1016\/j.surg.2019.06.005","journal-title":"Surgery"},{"issue":"8","key":"10203_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00270-022-03183-2","volume":"45","author":"AN Gupta","year":"2022","unstructured":"Gupta AN, Gordon AC, Gabr A, Kalyan A, Kircher SM, Mahalingam D, Mulcahy MF, Merkow RP, Yang AD, Bentrem DJ, Caicedo-Ramirez JC, Riaz A, Thornburg B, Desai K, Sato KT, Hohlastos ES, Kulik L, Benson AB, Salem R, Lewandowski RJ (2022) Yttrium-90 radioembolization of unresectable intrahepatic cholangiocarcinoma: long-term follow-up for a 136-patient cohort. Cardiovasc Intervent Radiol 45(8):1117\u20131128. https:\/\/doi.org\/10.1007\/s00270-022-03183-2","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"10203_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00330-022-09131-5","volume":"33","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Zheng X, Zhou C, Huang P, Wu F, Yang C, Zeng M (2023) Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. Eur Radiol 33(2):1412\u20131421. https:\/\/doi.org\/10.1007\/s00330-022-09131-5","journal-title":"Eur Radiol"},{"issue":"6","key":"10203_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jvir.2015.01.038","volume":"26","author":"DC Sukato","year":"2015","unstructured":"Sukato DC, Tohme S, Chalhoub D, Han K, Zajko A, Amesur N, Orons P, Marsh JW, Geller DA, Tsung A (2015) The prognostic role of neutrophil-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma treated with radioembolization. J Vasc Interv Radiol 26(6):816-824.e1. https:\/\/doi.org\/10.1016\/j.jvir.2015.01.038","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"10203_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00270-022-03183-2","volume":"45","author":"AN Gupta","year":"2022","unstructured":"Gupta AN, Gordon AC, Gabr A et al (2022) Yttrium-90 radioembolization of unresectable intrahepatic cholangiocarcinoma: long-term follow-up for a 136-patient cohort. CardioVasc Interv Radiol. 45(8):1117\u20131128","journal-title":"CardioVasc Interv Radiol."},{"key":"10203_CR18","doi-asserted-by":"crossref","unstructured":"Paprottka KJ, Gali\u00e8 F, Ingrisch M, et al Outcome and safety after 103 radioembolizations with yttrium-90 resin microspheres in 73 patients with unresectable intrahepatic cholangiocarcinoma\u2014an evaluation of predictors. Cancers. 2021;13(21):5399.","DOI":"10.3390\/cancers13215399"},{"issue":"9","key":"10203_CR19","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00270-020-02569-4","volume":"43","author":"I Bargellini","year":"2020","unstructured":"Bargellini I, Mosconi C, Pizzi G et al (2020) Yttrium-90 radioembolization in unresectable intrahepatic cholangiocarcinoma: results of a multicenter retrospective study. Cardiovasc Interv Radiol. 43(9):1305\u20131314","journal-title":"Cardiovasc Interv Radiol."},{"issue":"11","key":"10203_CR20","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.jvir.2021.08.009","volume":"32","author":"A Sarwar","year":"2021","unstructured":"Sarwar A, Ali A, Ljuboja D, Weinstein JL, Shenoy-Bhangle AS, Nasser IA, Morrow MK, Faintuch S, Curry MP, Bullock AJ, Ahmed M (2021) Neoadjuvant Yttrium-90 transarterial radioembolization with resin microspheres prescribed using the medical internal radiation dose model for intrahepatic cholangiocarcinoma. J Vasc Interv Radiol 32(11):1560\u20131568. https:\/\/doi.org\/10.1016\/j.jvir.2021.08.009","journal-title":"J Vasc Interv Radiol"},{"issue":"9","key":"10203_CR21","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1245\/s10434-014-4365-3","volume":"22","author":"M Rayar","year":"2015","unstructured":"Rayar M, Sulpice L, Edeline J, Garin E, Levi Sandri GB, Meunier B, Boucher E, Boudjema K (2015) Intra-arterial Yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Ann Surg Oncol 22(9):3102\u20133108. https:\/\/doi.org\/10.1245\/s10434-014-4365-3","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10203_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.32258","volume":"75","author":"G Sapisochin","year":"2022","unstructured":"Sapisochin G, Ivanics T, Heimbach J (2022) Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time? Hepatology. 75(2):455\u2013472","journal-title":"Hepatology."},{"issue":"8","key":"10203_CR23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ejrad.2016.05.020","volume":"85","author":"L Beuzit","year":"2016","unstructured":"Beuzit L, Edeline J, Brun V, Ronot M, Guillygomarc\u2019h A, Boudjema K, Gandon Y, Garin E, Rolland Y (2016) Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT). Eur J Radiol 85(8):1445\u20131452. https:\/\/doi.org\/10.1016\/j.ejrad.2016.05.020","journal-title":"Eur J Radiol"},{"issue":"11","key":"10203_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/RLU.0000000000000557","volume":"39","author":"JC Camacho","year":"2014","unstructured":"Camacho JC, Kokabi N, Xing M, Schuster DM, Kim HS (2014) PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma. Clin Nucl Med 39(11):944\u2013950. https:\/\/doi.org\/10.1097\/RLU.0000000000000557","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10203_CR25","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jvir.2019.03.018","volume":"30","author":"J White","year":"2019","unstructured":"White J, Carolan-Rees G, Dale M et al (2019) Yttrium-90 transarterial radioembolization for chemotherapy-refractory intrahepatic cholangiocarcinoma: a prospective, observational study. J Vasc Interv Radiol. 30(8):1185\u20131192","journal-title":"J Vasc Interv Radiol."},{"issue":"1","key":"10203_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2549-x","volume":"16","author":"R Damm","year":"2016","unstructured":"Damm R, Seidensticker R, Ulrich G et al (2016) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system. BMC Cancer. 16(1):1\u20137","journal-title":"BMC Cancer."},{"key":"10203_CR27","doi-asserted-by":"publisher","unstructured":"Oh D-Y, He AR, Qin S, Chen LT, Okusaka T, Vogel A, Kim JW, Suksombooncharoen T, Ah Lee M, Kitano M, Burris H, Bouattour, M, Tanasanvimon S, McNamara MG, Zaucha R, Avallone A, Tan B, Cundom J, Lee\u00a0C-k, Takahashi H, Ikeda M, Chen\u00a0J-S, Wang J, Makowsky M, Rokutanda N, He P, Kurland JF, Cohen G, Valle JW (2022) Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid 1(8). https:\/\/doi.org\/10.1056\/EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015"},{"key":"10203_CR28","doi-asserted-by":"publisher","unstructured":"Goyal L, Kongpetch S, Crolley VE, Bridgewater J (2021) Targeting FGFR inhibition in cholangiocarcinoma. Cancer Treat Rev 95:102170. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102170","DOI":"10.1016\/j.ctrv.2021.102170"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10203-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:10:48Z","timestamp":1711012248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10203-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["10203"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10203-3","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Qian Yu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained (University of Chicago).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Retrospective\u2022 Observational study\u2022 Performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}